Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Natera
AddedFeb 15, 2024
UpdatedJun 28, 2026
Natera

Natera

Public

Natera, Inc. is a US-based clinical genetic testing firm specializing in non-invasive DNA testing for women's health, cancer, and organ health.

HQ
Austin, TX, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Natera, Inc., founded in 2004 by Matthew Rabinowitz and Jonathan Sheena, is a clinical genetic testing company headquartered in Austin, Texas. The company's core mission is to transform the management of disease worldwide through genetic insights. Natera specializes in non-invasive, cell-free DNA (cfDNA) testing technology, focusing on women's health, oncology, and organ health. Their proprietary technology integrates advanced molecular biology techniques with sophisticated bioinformatics software, enabling the detection of genetic anomalies from a single molecule in a blood sample.

Notable figures associated with Natera include its founders, Matthew Rabinowitz and Jonathan Sheena. The company has attracted significant investment and is publicly traded on the Nasdaq under the ticker symbol NTRA. Key achievements include the development of groundbreaking cfDNA tests and the operation of CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments. Natera's impact is profound, offering critical genetic insights that aid in early detection and management of various health conditions, thereby improving patient outcomes globally.

Natera - Similar Companies

Invitae logo

Invitae

invitae.com

Fulgent Genetics logo

Fulgent Genetics

Cradle Genomics logo

Cradle Genomics

23andMe logo

23andMe

23andme.com

GeneDx Holdings logo

GeneDx Holdings

genedx.com

Luna Genetics logo

Luna Genetics

Cellscape logo

Cellscape

Myriad Genetics logo

Myriad Genetics

myriad.com

Color logo

Color

color.com

Ravgen logo

Ravgen

ravgen.com

Karius logo

Karius

kariusdx.com

Pathway Genomics logo

Pathway Genomics

Genetica logo

Genetica

genetica.asia

Nest Genomics logo

Nest Genomics

nestgenomics.com

Bluestar Genomics logo

Bluestar Genomics

Natera - Quick Facts

Who are Natera's competitors?

Companies similar to Natera include Invitae, Fulgent Genetics, Cradle Genomics and 23andMe.

When was Natera founded?

Natera was founded in 2004.

Where is Natera's headquarters located?

Natera's headquarters is located in Austin, TX, US.

When was Natera's last funding round?

Natera's most recent funding round was for $250M (USD) in September 2023.

How much has Natera raised to-date?

As of Sep 7, 2023, Natera has raised a total of $1.2B (USD).

How many employees does Natera have?

Natera has 3,018 employees as of Feb 6, 2024.

Natera - Classification

Ownership
  • Public
Technology
  • Analytics
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Genetic Testing
Tags
  • Healthcare
  • Healthtech
Unique IDs
  • ein: 010894487
  • secCik: 0001604821
  • ticker: NTRA
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories
  • 8000Health Services
ISIC
  • 8690Other human health activities
Show 24 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
  • 621512Diagnostic Imaging Centers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 6000Depository Institutions
  • 7300Business Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research